News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Conference News EuroPCR 2023 QFR More Consistent Than FFR in Nonculprit Lesions After STEMI Caitlin E. Cox May 24, 2023
News Conference News EuroPCR 2021 Subcutaneous GP IIb/IIIa Inhibitor in STEMI Is Fast, Potent in Early Study Todd Neale May 18, 2021
News Conference News EuroPCR 2020 Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients Michael O'Riordan June 30, 2020
News Conference News AHA 2018 Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia Michael O'Riordan November 11, 2018
News Conference News EuroPCR 2018 Ticagrelor Doesn’t Carry Any Off-Target Effects Compared With Clopidogrel, Prasugrel Yael L. Maxwell May 30, 2018
News Conference News EuroPCR 2017 iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows Caitlin E. Cox May 16, 2017
News Conference News ACC 2017 iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions Caitlin E. Cox March 18, 2017
News Conference News EuroPCR 2016 Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease Caitlin E. Cox May 19, 2016
News Conference News ESC 2015 CIRCUS: Transplant Rejection Drug Fails to Reduce Infarct Size in Anterior STEMI L.A. McKeown August 30, 2015
News Conference News ESC 2013 PROMISE: Intracoronary Adenosine Effective in STEMI Patients with Shorter Ischemic Times September 03, 2013
News Conference News ACC 2013 SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI Caitlin E. Cox March 12, 2013
News Conference News Adenosine-Free Pressure Measurement Found Equivalent to FFR L.A. McKeown December 01, 2011